What Patients Should Not Do After GLP-1 Weight Loss Patients should not treat GLP-1 success as permission to stop paying attention to metabolic health
This is a preview of subscription content, access via your institution Access options Subscribe to this journal Receive 12 print issues and online access 261,46 per year only 21,79 per issue Buy this article Purchase on SpringerLink Instant access to the full article PDF
Insulin resistance in liver and adipose tissue The liver critically controls postprandial carbohydrate levels by suppressing HGP and stimulating the deposition of glucose as glycogen and is the primary source of glucose production during fasting [35]
Tao J, Jia S, Wang M, Huang Z, Wang B, Zhang W, Wei Y, Li W, Jiang H, Du Z (2021) Systematic identification of proteins binding with Cisplatin in blood by affinity chromatography and a four-dimensional proteomic method
Morgan & Morgan fights to recover not just medical costs but also lost wages, pain and suffering, emotional distress, and loss of enjoyment of life
Real-world reports suggest a lower incidence than nausea or fatigue, making it a less common but recognized response